Management of patients with hepatitis B in special populations.

@article{Cholongitas2015ManagementOP,
  title={Management of patients with hepatitis B in special populations.},
  author={Evangelos B Cholongitas and Konstantinos Tziomalos and Chrysoula Leonidas Pipili},
  journal={World journal of gastroenterology},
  year={2015},
  volume={21 6},
  pages={
          1738-48
        }
}
The development of effective nucleos(t)ide analogs (NAs) against hepatitis B virus (HBV) has improved the outcome of patients with chronic hepatitis B (CHB). This review updates issues related to the management of CHB patients included in special populations. Entecavir (ETV) and tenofovir (TDF) represent the currently recommended first-line NAs in patients with HBV decompensated cirrhosis. The combination of HBV immunoglobulin (usually for a finite duration) and NA is considered the standard of… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS

Similar Papers

Loading similar papers…